Skip to main content
About InfiMed AI

Care should not wait on a fax machine.

We build software for the gap between a clinician deciding what a patient needs and a payer agreeing to cover it. That gap costs American medicine billions of dollars and an enormous amount of goodwill every year. We think it is an engineering problem.

Authorization requests per physician each week
39Authorization requests per physician each week
Weekly staff time spent on those requests
13 hrsWeekly staff time spent on those requests
Of physicians report authorization delays care
93%Of physicians report authorization delays care
Report patients abandoning treatment as a result
78%Report patients abandoning treatment as a result
Our mission

Put the clinic's attention back on patients.

Prior authorization began as a check on unnecessary spending. It has become a volume business: tens of requests per physician per week, each one a form, a portal login, a hold queue and a follow-up nobody has time for.

The cost is not only financial. Physicians name it among the leading contributors to burnout, and practices routinely watch patients walk away from treatment their clinician already judged necessary while an approval sits in limbo.

We are not trying to abolish the process — that is a policy fight, and a slow one. We are trying to make it cost a clinic thirty seconds instead of thirty minutes, and to make sure a wrong answer gets challenged properly every single time.

The crisis in numbers

What prior authorization actually costs.

Figures drawn from the American Medical Association's 2024 physician survey and published payer and regulatory reporting.

Say prior authorization contributes to burnout
89%Say prior authorization contributes to burnout
Report patients abandoning recommended treatment
78%Report patients abandoning recommended treatment
Americans had a claim denied in a single year
73MAmericans had a claim denied in a single year
Of insurers use AI in utilization management
71%Of insurers use AI in utilization management
Say the process raises overall cost of care
88%Say the process raises overall cost of care
Are concerned insurer AI is increasing denials
61%Are concerned insurer AI is increasing denials
The asymmetry

One side automated. The other side did not.

Utilization review has been machine-assisted for years. The response to it is still assembled by hand, under time pressure, by people who would rather be with patients. That imbalance is the whole problem.

How review works now

  • Requests screened against policy rules in seconds
  • Denials issued at a scale no clinic can match
  • Appeal windows short enough to run out quietly
  • Criteria that change without a changelog

How InfiMed AI responds

  • Requests assembled to match the policy before they are sent
  • Denials answered within minutes, not weeks
  • Deadlines tracked automatically, with alerts before they close
  • Policy library maintained so your forms stay current
How we got here

Built out of somebody else's bad Thursday.

  1. The problem

    A queue nobody owned

    We started by sitting with practice staff and counting. The authorization queue was never anyone's actual job — it was absorbed between other work, which is exactly why it never got faster.

  2. The tipping point

    A denial found too late

    In one pilot clinic, a denial sat unread long enough that the appeal window closed. The therapy was approved eventually, months later. Nothing about that failure was clinical.

  3. The insight

    The bottleneck is reading, not deciding

    Almost all of the time goes into reading a chart, matching it to a policy, and restating both in a payer's format. Clinicians were never the slow part. Transcription was.

  4. The solution

    An agent that does the reading

    So we built one that reads the chart, matches the policy, drafts the request and the rebuttal, and hands a clinician something to check rather than something to write.

What we believe

Six things we will not trade away.

  • Patients before paperwork

    Every decision gets measured against one question: does this get a patient treated sooner? If not, it is not a priority.

  • Speed is a clinical feature

    A delay is not an inconvenience, it is a health outcome. We treat latency in this workflow the way you would treat it in a monitor.

  • Privacy is not a tier

    Encryption, least-privilege access, audit logging and a signed BAA come with every plan. Security is not something you upgrade into.

  • Show your sources

    Nothing the model asserts goes out unsourced. Every extracted fact and quoted guideline links back to where it came from.

  • Built with clinics, not at them

    Our roadmap comes from the people working the queue. They are the ones who know which fields payers actually reject.

  • Measured, not asserted

    We report on your authorization volume, your approval rates and your recovered hours — not on a benchmark you cannot verify.

Our team

Clinicians and engineers, in the same room.

InfiMed AI is built by people who have worked both sides of this problem — revenue cycle and utilization management on one hand, applied machine learning and health data infrastructure on the other. Nurses review what the model drafts. Engineers sit in on payer calls. That is deliberate: this product breaks the moment it is built by people who have never watched a practice manager fight a fax machine at 6pm.

Sources

  1. 1.American Medical Association, 2024 Prior Authorization Physician Survey — burden, delay and treatment-abandonment figures.
  2. 2.Published payer transparency and regulatory reporting on claim denial volume.
  3. 3.Industry surveys of utilization management automation among commercial insurers.
  4. 4.CMS interoperability and prior authorization final rule, on payer API requirements and decision timeframes.

Take your week back.

Thirty minutes with your own numbers will tell you more than any case study we could write.

No card required · Guided pilot · HIPAA-aligned from day one